acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study

[Background] There is an unmet need for non-invasive biomarkers for the diagnosis of nonalcoholic steatohepatitis (NASH) in non-specialized settings. We aimed to develop and validate a non-invasive test for diagnosing NASH in individuals with biopsy-proven nonalcoholic fatty liver disease (NAFLD).

Detalles Bibliográficos
Autores: Wu, Xi-Xi, Zheng, Kenneth I., Boursier, Jerome, Chan, Wah-Kheong, Yilmaz, Yusuf, Romero-Gómez, Manuel, El Kassas, Mohamed, Targher, Giovanni, Byrne, Christopher D., Huang, Zhi-Ming, Zheng, Ming-Hua
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/269142
Acceso en línea:http://hdl.handle.net/10261/269142
Access Level:acceso abierto
Palabra clave:Nonalcoholic steatohepatitis
Primary care
Screening
Metabolic dysfunction-associated fatty liver disease
Nonalcoholic fatty liver disease
scoring system
Descripción
Sumario:[Background] There is an unmet need for non-invasive biomarkers for the diagnosis of nonalcoholic steatohepatitis (NASH) in non-specialized settings. We aimed to develop and validate a non-invasive test for diagnosing NASH in individuals with biopsy-proven nonalcoholic fatty liver disease (NAFLD).